Chargement en cours...
Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity
Though the pathophysiology of clinical obesity is undoubtedly multifaceted, several lines of clinical evidence implicate an important functional role for glucagon-like peptide 1 (GLP-1) signalling. Clinical studies assessing GLP-1 responses in normal weight and obese subjects suggest that weight gai...
Enregistré dans:
| Publié dans: | World J Diabetes |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Baishideng Publishing Group Inc
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5155232/ https://ncbi.nlm.nih.gov/pubmed/28031776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4239/wjd.v7.i20.572 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|